| Literature DB >> 22876232 |
Eva Wrobel1, Daniel Tapken, Guiscard Seebohm.
Abstract
The classical tango is a dance characterized by a 2/4 or 4/4 rhythm in which the partners dance in a coordinated way, allowing dynamic contact. There is a surprising similarity between the tango and how KCNE β-subunits "dance" to the fast rhythm of the cell with their partners from the Kv channel family. The five KCNE β-subunits interact with several members of the Kv channels, thereby modifying channel gating via the interaction of their single transmembrane-spanning segment, the extracellular amino terminus, and/or the intracellular carboxy terminus with the Kv α-subunit. Best studied is the molecular basis of interactions between KCNE1 and Kv7.1, which, together, supposedly form the native cardiac I(Ks) channel. Here we review the current knowledge about functional and molecular interactions of KCNE1 with Kv7.1 and try to summarize and interpret the tango of the KCNEs.Entities:
Keywords: KCNE1; Kv channel; Kv7.1; β-subunit
Year: 2012 PMID: 22876232 PMCID: PMC3410610 DOI: 10.3389/fphar.2012.00142
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Figure 1Distribution of Kv7.1. Kv7.1 is expressed in several tissues throughout the human body, including heart, lung, inner ear, kidney, and the gastrointestinal tract.
Kv7.1 expression in mammalian tissues.
| Specified tissue | Species | mRNA/protein | Reference |
|---|---|---|---|
| Brain | Mouse | mRNA | Lee et al. ( |
| Mouse | mRNA | Ohya et al. ( | |
| Mouse | mRNA | Yeung et al. ( | |
| Mouse | mRNA | Iannotti et al. ( | |
| Inner ear | Mouse | mRNA | Neyroud et al. ( |
| Mouse | mRNA/protein | Nicolas et al. ( | |
| Mouse | Protein | Knipper et al. ( | |
| Rat | mRNA | Liang et al. ( | |
| Rat | Protein | Hur et al. ( | |
| Guinea pig | mRNA | Liang et al. ( | |
| Trachea | Mouse | mRNA/protein | Grahammer et al. ( |
| Thyroid gland | Mouse | mRNA/protein | Frohlich et al. ( |
| Human | mRNA | Yang et al. ( | |
| Human | mRNA | Frohlich et al. ( | |
| Thymus | Mouse | mRNA | Demolombe et al. ( |
| Human | mRNA | Chouabe et al. ( | |
| Lung | Mouse | mRNA | Demolombe et al. ( |
| Human | mRNA | Wang et al. ( | |
| Human | mRNA | Sanguinetti et al. ( | |
| Human | mRNA | Chouabe et al. ( | |
| Human | mRNA | Yang et al. ( | |
| Heart | Mouse | mRNA | Barhanin et al. ( |
| Mouse | mRNA | Lee et al. ( | |
| Mouse | mRNA | Casimiro et al. ( | |
| Mouse | mRNA | Demolombe et al. ( | |
| Mouse | mRNA | Ohya et al. ( | |
| Mouse | mRNA | Yeung et al. ( | |
| Mouse | mRNA | Iannotti et al. ( | |
| Mouse | mRNA | Strutz-Seebohm et al. ( | |
| Mouse | Protein | Knollmann et al. ( | |
| Rat | Protein | Rasmussen et al. ( | |
| Guinea pig | mRNA/protein | Zicha et al. ( | |
| Guinea pig | Protein | Nicolas et al. ( | |
| Ferret | mRNA | Brahmajothi et al. ( | |
| Rabbit | mRNA/protein | Zicha et al. ( | |
| Horse | Protein | Finley et al. ( | |
| Canine | mRNA/protein | Han et al. ( | |
| Human | mRNA | Wang et al. ( | |
| Human | mRNA | Sanguinetti et al. ( | |
| Human | mRNA | Chouabe et al. ( | |
| Human | mRNA | Yang et al. ( | |
| Human | mRNA | Bendahhou et al. ( | |
| Human | mRNA | Gaborit et al. ( | |
| Human | mRNA | Frohlich et al. ( | |
| Human | mRNA/protein | Zicha et al. ( | |
| Liver | Mouse | mRNA | Lee et al. ( |
| Mouse | mRNA | Demolombe et al. ( | |
| Spleen | Mouse | mRNA | Demolombe et al. ( |
| Human | mRNA | Chouabe et al. ( | |
| Pancreas | Mouse | mRNA | Demolombe et al. ( |
| Rat | Protein | Lee et al. ( | |
| Human | mRNA | Sanguinetti et al. ( | |
| Human | mRNA | Chouabe et al. ( | |
| Human | mRNA | Yang et al. ( | |
| Stomach | Mouse | mRNA | Lee et al. ( |
| Mouse | mRNA | Demolombe et al. ( | |
| Mouse | mRNA/protein | Dedek and Waldegger ( | |
| Mouse | Protein | Grahammer et al. ( | |
| Mouse | Protein | Heitzmann et al. ( | |
| Mouse | Protein | Heitzmann and Warth ( | |
| Rat | mRNA/protein | Lambrecht et al. ( | |
| Human | mRNA | Yang et al. ( | |
| Human | mRNA | Frohlich et al. ( | |
| Human | Protein | Grahammer et al. ( | |
| Colon | Mouse | mRNA/protein | Dedek and Waldegger ( |
| Rat | mRNA | Kunzelmann et al. ( | |
| Human | mRNA | Chouabe et al. ( | |
| Human | mRNA | Yang et al. ( | |
| Human | mRNA | Frohlich et al. ( | |
| Human | mRNA/protein | Horikawa et al. ( | |
| Small intestine | Mouse | mRNA | Demolombe et al. ( |
| Mouse | mRNA/protein | Dedek and Waldegger ( | |
| Human | mRNA | Chouabe et al. ( | |
| Human | mRNA | Yang et al. ( | |
| Kidney | Mouse | mRNA | Barhanin et al. ( |
| Mouse | mRNA | Lee et al. ( | |
| Mouse | mRNA | Demolombe et al. ( | |
| Mouse | Protein | Vallon et al. ( | |
| Human | mRNA | Wang et al. ( | |
| Human | mRNA | Sanguinetti et al. ( | |
| Human | mRNA | Chouabe et al. ( | |
| Human | mRNA | Yang et al. ( | |
| Uterus | Mouse | mRNA/protein | McCallum et al. ( |
| Placenta | Human | mRNA | Wang et al. ( |
| Human | mRNA | Sanguinetti et al. ( | |
| Human | mRNA | Chouabe et al. ( | |
| Human | mRNA | Yang et al. ( | |
| Ovary | Human | mRNA | Chouabe et al. ( |
| Prostate | Human | mRNA | Chouabe et al. ( |
| Human | mRNA | Yang et al. ( | |
| Testis | Human | mRNA | Chouabe et al. ( |
| Blood vessels | Mouse | mRNA/protein | Ohya et al. ( |
| Mouse | mRNA/protein | Yeung et al. ( | |
| Rat | mRNA | Brueggemann et al. ( | |
| Rat | mRNA | Mackie et al. ( | |
| Rat | mRNA | Joshi et al. ( | |
| Rat | mRNA/protein | Zhong et al. ( | |
| Human | mRNA/protein | Ng et al. ( | |
| Skeletal muscle | Mouse | mRNA | Demolombe et al. ( |
| Mouse | mRNA | Iannotti et al. ( | |
| Rat | mRNA | Roura-Ferrer et al. ( | |
| Peripheral blood leukocytes | Human | mRNA | Chouabe et al. ( |
| Hematopoietic stem cells | Human | mRNA | Park et al. ( |
Figure 2Characteristics of Kv7.1/KCNE-mediated currents. (A) Representative current traces of Kv7.1 homomers and Kv7.1/KCNE1 heteromers. Channels were expressed in Xenopus oocytes, and currents were elicited with 7 s pulses to potentials of −100 to +60 mV, applied in 20 mV increments from a holding potential of −80 mV. Tail currents were recorded at −120 mV. (B) Current-voltage relationships. At voltages between −60 and −40 mV KCNE1 suppresses currents, whereas it stimulates them at voltages above 0 mV. (C) Voltage dependence of channel activation determined by tail current analysis. Activation curves were fitted to a Boltzmann function. Note: Kv7.1/KCNE1 channels are not fully activated at +60 mV. (D) Effects of different KCNE subunits on Kv7.1 currents. “+” and “++” indicate increased and strongly increased effects, while “−” and “−−” indicate decreased and strongly decreased effects, respectively. *Effect shown in the calmodulin binding-deficient KCNE4L69–L72 mutant (Ciampa et al., 2011). The Rb+/K+ conductance tightly correlates with the partial inactivation, and KCNE5 slightly increases it, whereas KCNE1/3 decreases it compared to Kv7.1 (Seebohm et al., 2003c).
Figure 3Topology and stoichiometry of Kv7.1/KCNE1 channels. (A) Kv7.1 α-subunits are made of six membrane-spanning segments S1–S6 and intracellular N- and C-terminal domains. The segments S1–S4 form the voltage-sensing domain (VSD), while the pore domain (PD) consists of segments S5 and S6. KCNE1 β-subunits contain a single transmembrane segment flanked by an extracellular N-terminus and a cytosolic C-terminus. (B) Four Kv7.1 α-subunits assemble to form a functional channel. The number of KCNE1 β-subunits associating with Kv7.1 tetramers is still a matter of extensive debate (Strutz-Seebohm et al., 2011).
Stoichiometry of Kv7.1/KCNE1 channels.
| Experimental evidence leading to conclusion of fixed stoichiometry (4:2) | Reference |
|---|---|
| Suppression of current induced by coexpression of wildtype and mutant KCNE1 indicates 4:2 stoichiometry | Wang and Goldstein ( |
| Kv7.1/Kv7.1/KCNE1 fusion proteins and naturally assembled Kv7.1/KCNE1 channels show similar characteristics of CTX inhibition; quantification of Kv7.1 and KCNE1 subunits using 3H-CTX and an antibody indicates a 4:2 stoichiometry | Chen et al. ( |
| Chemical subunit counting experiments indicate that association of two KCNE1 subunits with the Kv7.1 tetramer is sufficient to induce KCNE1-typical modulation of channel properties | Morin and Kobertz ( |
| Computational model of Kv7.1/KCNE1 channels indicates that binding of more than two KCNE1 subunits to the Kv7.1 tetramer might be sterically hindered | Kang et al. ( |
| Current amplitude, activation kinetics, and voltage dependence of Kv7.1/KCNE1 channels vary with the amount of KCNE1 | Cui et al. ( |
| Both Kv7.1/KCNE1 fusion proteins and Kv7.1–Kv7.1 with additional KCNE1 produce currents with activation kinetics and voltage dependence similar to naturally assembled Kv7.1/KCNE1 channels | Wang et al. ( |
| Voltage dependence of activation of Kv7.1/KCNE1 channels varies with the amount of KCNE1 | Morokuma et al. ( |
| Single-molecule fluorescent bleaching studies indicate that up to four KCNE1 subunits associate with the Kv7.1 tetramer depending on the relative densities of the two subunits | Nakajo et al. ( |
| Effects of free KCNE1 C-terminals on voltage dependence of activation of Kv7.1 and Kv7.1/KCNE1 channels are complex, indicating multiple stoichiometries or saturation of possible binding sites | Zheng et al. ( |
| Overexpression of KCNE1 markedly changed activation kinetics and voltage dependence of native | Wang et al. ( |
| Modeling of transmembrane domain suggests that variable stoichiometry seems possible in this region | Strutz-Seebohm et al. ( |
Structural basis of Kv7.1/KCNE1 interaction.
| Approach | Conclusion | Reference |
|---|---|---|
| Deletion analysis, chimeric approach, and/or site-directed mutagenesis | TM segment and cytoplasmic portion immediately following TM segment of KCNE1 mediate KCNE1 function | Takumi et al. ( |
| TM segment and C-terminal domain of KCNE1 mediate KCNE1 function | Tapper and George ( | |
| Residues 57–59 of KCNE1 are important for KCNE1 function (“activation triplet”) | Melman et al. ( | |
| Residue L273 of Kv7.1 is important for normal modulation by KCNE1 | Seebohm et al. ( | |
| Residue T58 is a key element of KCNE1 function | Melman et al. ( | |
| Requirements to interact with KCNE1 are located in regions C-terminal to S5; Residues S338, F339, and F340 in S6 are important for normal modulation by KCNE1 | Melman et al. ( | |
| Residues S338, F339, and F340 in S6 are possible interaction sites of KCNE1 | Panaghie et al. ( | |
| KCNE1 C-terminus is crucial for channel assembly, open state destabilization, kinetics of deactivation | Chen et al. ( | |
| Amino acids important for normal modulation by KCNE1 are located in S5 and S6 (G272, V324, V334) of Kv7.1 | Nakajo et al. ( | |
| Cysteine scanning mutagenesis combined with chemical modifications (Cd2+ coordination, MTS reagent binding, and spontaneous disulfide formation) | TM segment of KCNE1 lines the conduction pathway | Wang et al. ( |
| TM segment of KCNE1 lines the conduction pathway | Tai and Goldstein ( | |
| KCNE1 is located outside the conduction pathway | Kurokawa et al. ( | |
| KCNE1 is located outside the conduction pathway but in very close proximity to S6 of Kv7.1 | Tapper and George ( | |
| E44 in KCNE1 is close to A226 in S4 of Kv7.1 in the open state; KCNE1 is close to or possibly interacts with the VSD | Nakajo and Kubo ( | |
| KCNE1 makes state-dependent contact with S1 of Kv7.1; KCNE1 is in close proximity to the VSD | Xu et al. ( | |
| KCNE1 is located close to S1 and S4 of two adjacent VSDs | Shamgar et al. ( | |
| C-terminal region directly following the KCNE1 TM segment interacts with activation gate of Kv7.1 | Lvov et al. ( | |
| Proof of direct physical interaction or close proximity (e.g., co-immunoprecipitation, FRET) | C-terminus of KCNE1 directly interacts with the pore region of Kv7.1 | Romey et al. ( |
| C-termini of Kv7.1 and KCNE1 move close to each other during channel activation; distal C-terminus of KCNE1 interacts with dimeric coiled coil helix C of Kv7.1 | Haitin et al. ( | |
| Physical interaction between C-termini of Kv7.1 and KCNE1; portion of A-helix and its linker to S6 bind KCNE1 | Zheng et al. ( | |
| Analysis of disease-causing mutations | Functional interaction of KCNE1 with S4/S4–S5 linker of Kv7.1 | Franqueza et al. ( |
| Functional interaction of KCNE1 with S4/S4–S5 linker of Kv7.1 | Chouabe et al. ( | |
| Functional interaction of KCNE1 with S1 of Kv7.1 | Chan et al. ( | |
| Computational model | KCNE1 is located in a cleft between the pore domain and the VSD of Kv7.1 | Kang et al. ( |
| KCNE1 binds to the outer face of the Kv7.1 channel pore, KCNE1 is located in a cleft between pore domain and VSD of Kv7.1 | Strutz-Seebohm et al. ( |
Figure 4Structural model of the Kv7.1 channel. The transmembrane domain of the Kv7.1 channel bears the common Kv channel structure. Homology models using the solved crystal structural constraints allow for good model predictions (gray). For docking experiments the solved NMR-structural data of the full-length KCNE1 in lipid environments can be used (here only the transmembrane segment is shown in red; Tian et al., 2007; Kang et al., 2008). The structure of the Kv7.1 tetrameric assembly domain (A-domain) was solved and can be incorporated into a model (Xu and Minor, 2009). The region linking the S6 and the A-domain shows amino acid similarity to the structure 1VNS.pdb. No structures or even template coordinates for the Kv7.1 N-terminus and the distal C-terminus are available and thus homology modeling is currently problematic.
Figure 5Dynamic model of gating transitions in Kv7.1/KCNE1 channels. The closed (C), pre-open (C*), and open (O) state models described by Smith et al. (2007) and Strutz-Seebohm et al. (2011) were used to generate dynamic models using simple morphing approaches. The gating of Kv7.1/KCNE1 channels can be approximated by a simplified circular gating model. Major gating steps are C ⇒ C* (A), C* ⇒ O (B), and O ⇒ C (C) (colors as indicated in the letters above the models). For clarity the central axes of the KCNE1 start and end models are marked by the yellow dashed lines, and the direction and extent of the proposed motion is indicated by the yellow arrow. In (A) the KCNE1 start model is shown in red and the end model in magenta. The morphs indicate larger motions of KCNE1 during channel gating in the gating cleft of Kv7.1 channels. A particularly large gating motion around Thr58 is seen from C* ⇒ O (B), suggesting a major energetic barrier. This may be the molecular basis of the dramatically slowed activation of Kv7.1 by association with KCNE1. However, calculation of energies on the models is highly speculative because specific interactions with surrounding membrane molecules [e.g., PI(4,5)P2] would be highly influential, and the current knowledge on lipid-channel interactions is not sufficient to allow for precise calculations.